LONG COVID- 'THE MYSTERY YET TO REVEAL'

Author:

Mallikarjun Tuppad Karthik1,B Archana2,S Parinita3,Shaji Georgin1,Akhila Chitteddi1

Affiliation:

1. Post Graduate

2. Hod & Professor

3. Associate Professor

Abstract

Introduction: The first case of covid19 in India on January 31,2020.India has presently achieved over 90% recovery.9.5 million cases recovered out of 10 million reported as of December 19,2020.However,as the cohort of survivors expands, it is now being realized that a parallel epidemic of the post-COVID syndrome/long COVID is emerging.Aim:To identify and manage long covid more efficiently. Objective:To record follow up data of covid 19 survivors.Materials & Method: This is the prospective cohort study including 150 patients of,all confirmed hospitalized patients who were discharged during 2nd wave of COVID 19 from RRMCH, Bangalore, patients were contacted by telephone. Duration for 6 months April 21 to October 21. Results:Patients were found to have a direct correlation with days of hospitalization (p-0.0001,R0.773) presence of co morbidities(p-0.0001) and history of smoking(p-0.006) with Chalder fatigue score. Patients with vaccination were found to have proportionately lower CFS scores thereby indicating the importance of vaccination in prevention of Long Covid complications. Conclusion:This study makes it evident that of those who survived COVID-19 illness a significant proportion is likely to experience a post-COVID syndrome up to 6 months after the active illness

Publisher

World Wide Journals

Subject

Sociology and Political Science,Applied Psychology,Religious studies,Social Psychology,Animal Science and Zoology,Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine,Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy,Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy,Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine,Microbiology,Parasitology,Infectious Diseases,Microbiology (medical),Molecular Biology,Immunology,Immunology and Allergy,General Medicine,General Medicine,Pathology and Forensic Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3